Literature DB >> 1986137

Hypertonic saline alters plasma clotting times and platelet aggregation.

R L Reed1, T D Johnston, Y Chen, R P Fischer.   

Abstract

Hypertonic (7.5%) saline (HS) is advocated for resuscitation of injured and burned patients. Recent animal studies indicate that HS increases bleeding during uncontrolled hemorrhage, although the mechanisms for this are unclear. To investigate potential anticoagulant effects of HS (without dextran), normal human plasma was serially diluted with either HS or normal (0.9%) saline (NS). Prothrombin times (PT), activated partial thromboplastin times (APTT), and platelet aggregation studies were performed. Significant (p less than 0.05) deteriorations in clotting tests and platelet aggregation developed when 10% or more of normal plasma was replaced by HS, whereas there was no effect from similar NS dilutions. Strong correlations were observed between clotting test changes and sodium concentrations (R2 greater than 0.80, p less than 0.0001). Thus, HS exhibits anticoagulant activity, but not at the usual small volumes necessary to produce hemodynamic improvement. Nevertheless, the anticoagulant effect may be more pronounced with ongoing clotting factor losses or with the addition of dextran.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986137     DOI: 10.1097/00005373-199101000-00002

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  12 in total

Review 1.  Hypertonic saline for cerebral edema.

Authors:  Alexandros L Georgiadis; José I Suarez
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

2.  Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13.

Authors:  Max Wohlauer; Ernest E Moore; Christopher C Silliman; Miguel Fragoso; Fabia Gamboni; Jeffrey Harr; Frank Accurso; Frank Wright; James Haenel; David Fullerton; Anirban Banerjee
Journal:  Crit Care Med       Date:  2012-09       Impact factor: 7.598

3.  Comparison of hypertonic saline and mannitol on whole blood coagulation in vitro assessed by thromboelastometry.

Authors:  Teemu Luostarinen; Tomohisa Niiya; Alexey Schramko; Per Rosenberg; Tomi Niemi
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

4.  In vitro impairment of whole blood coagulation and platelet function by hypertonic saline hydroxyethyl starch.

Authors:  Alexander A Hanke; Stephanie Maschler; Herbert Schöchl; Felix Flöricke; Klaus Görlinger; Klaus Zanger; Peter Kienbaum
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-02-10       Impact factor: 2.953

Review 5.  Hypertonic saline: a clinical review.

Authors:  R Tyagi; K Donaldson; C M Loftus; J Jallo
Journal:  Neurosurg Rev       Date:  2007-06-16       Impact factor: 3.042

6.  Half-molar sodium-lactate solution has a beneficial effect in patients after coronary artery bypass grafting.

Authors:  Xavier M Leverve; Cindy Boon; Tarmizi Hakim; Maizul Anwar; Erwin Siregar; Iqbal Mustafa
Journal:  Intensive Care Med       Date:  2008-06-18       Impact factor: 17.440

7.  Infarct volume after hyperacute infusion of hypertonic saline in a rat model of acute embolic stroke.

Authors:  Alexander Papangelou; Thomas J K Toung; Allan Gottschalk; Marek A Mirski; Raymond C Koehler
Journal:  Neurocrit Care       Date:  2013-02       Impact factor: 3.210

Review 8.  Coagulopathy: its pathophysiology and treatment in the injured patient.

Authors:  Brandon H Tieu; John B Holcomb; Martin A Schreiber
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

9.  Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients.

Authors:  Shawn G Rhind; Naomi T Crnko; Andrew J Baker; Laurie J Morrison; Pang N Shek; Sandro Scarpelini; Sandro B Rizoli
Journal:  J Neuroinflammation       Date:  2010-01-18       Impact factor: 8.322

10.  In vitro effects of 3% hypertonic saline and 20% mannitol on canine whole blood coagulation and platelet function.

Authors:  Katja-Nicole Adamik; Emmanuelle Butty; Judith Howard
Journal:  BMC Vet Res       Date:  2015-09-24       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.